المؤلفون: Locati, Ld, De Cecco, L, Perrone, F, Cortelazzi, B, Gloghini, A, Volpi, C, Pilotti, S, Granata, R, Bossi, P, Orlandi, E, Resteghini, C, Alfieri, S, Bergamini, C, Cau, Mc, Imbimbo, M, Quattrone, P, Canevari, S, Licitra, Lf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3662::1990e45e1face189d798fae68a35e71d
http://hdl.handle.net/11379/515328

المؤلفون: Siano, M, Resteghini, C, Cau, Mc, Alfieri, S, Bergamini, C, Granata, R, Miceli, R, Infante, G, Locati, L, Licitra, L, Bossi, P

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3662::9c050c06f710c5e320c4141b0234b224
http://hdl.handle.net/11379/515304

المؤلفون: Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research Unit, Saint-Cloud, France.; Faculty of Medicine, Paris-Saclay University, Paris, France., Ghiani M; Department of Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy., Cau MC; Department of Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy., Depenni R; Department of Oncology and Hematology, Università degli Studi di Modena e Reggio Emilia, Modena, Italy., Ronzino G; Oncology Unit, Ospedale, Vito Fazzi, Lecce, Italy., Bonomo P; Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Montesarchio V; AORN dei Colli, Monaldi Hospital, Naples, Italy., Leo L; AORN dei Colli, Monaldi Hospital, Naples, Italy., Schulten J; Global Medical Unit Oncology, Merck Healthcare KGaA, Darmstadt, Germany., Salmio S; Global Medical Unit Oncology, Merck Healthcare KGaA, Darmstadt, Germany., Messinger D; Statistics, Prometris GmbH, Mannheim, Germany., Sbrana A; Service of Pneumo-Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Ghi MG; Oncology Unit 2, Istituto Oncologico Veneto-IRCCS, Padova, Italy.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 May; Vol. 6 (5), pp. e1804. Date of Electronic Publication: 2023 Apr 17.

نوع المنشور: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Platinum*/therapeutic use , Head and Neck Neoplasms*/drug therapy, Humans ; Cetuximab/adverse effects ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Carboplatin ; Prospective Studies ; Neoplasm Recurrence, Local/pathology ; Fluorouracil ; Cisplatin

المؤلفون: Cavalieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy. Electronic address: stefano.cavalieri@istitutotumori.mi.it., Mariani L; Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Vander Poorten V; Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven and Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium., Van Breda L; Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven and Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium., Cau MC; Medical Oncology Unit, Azienda Ospedaliera Brotzu, Cagliari, Italy., Lo Vullo S; Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Alfieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Resteghini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Bergamini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Orlandi E; Radiotherapy 1-2 Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Calareso G; Radiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Clement P; Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Hauben E; Department of Pathology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Platini F; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Bossi P; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Italy., Locati LD; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 35-42. Date of Electronic Publication: 2020 Jul 03.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Nomograms*, Carcinoma, Adenoid Cystic/*diagnosis , Salivary Gland Neoplasms/*diagnosis, Adult ; Aged ; Belgium/epidemiology ; Carcinoma, Adenoid Cystic/mortality ; Carcinoma, Adenoid Cystic/pathology ; Carcinoma, Adenoid Cystic/therapy ; Cohort Studies ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Salivary Gland Neoplasms/mortality ; Salivary Gland Neoplasms/pathology ; Salivary Gland Neoplasms/therapy ; Survival Analysis

المؤلفون: Siano M; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy; Cantonal Hospital St. Gallen, Dept. of Med. Oncology and Hematology, Rorschacherstrasse 95, CH-9007 St. Gallen, Switzerland. Electronic address: marco.siano@kssg.ch., Infante G; Fondazione IRCCS I.N.T., Clin. Epidemiology and Trials Org. Unit, I-20133 Milan, Italy; Politecnic University Milan, Piazza Leonardo da Vinci, 32, I-20133 Milano, Italy., Resteghini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Cau MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Alfieri S; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Bergamini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Granata R; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Miceli R; Fondazione IRCCS I.N.T., Clin. Epidemiology and Trials Org. Unit, I-20133 Milan, Italy., Locati L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy; State University of Milan, Via Festa del Perdono, 7, I-20122 Milano, Italy., Bossi P; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy.

المصدر: Oral oncology [Oral Oncol] 2017 Jun; Vol. 69, pp. 33-37. Date of Electronic Publication: 2017 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Metastasis* , Neoplasm Recurrence, Local*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carboplatin/*administration & dosage , Carcinoma, Squamous Cell/*drug therapy , Cetuximab/*administration & dosage , Cisplatin/*administration & dosage , Head and Neck Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/pathology ; ErbB Receptors/antagonists & inhibitors ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Squamous Cell Carcinoma of Head and Neck ; Survival Analysis ; Treatment Outcome

المؤلفون: Madeddu C; Department of Medical Oncology, University of Cagliari, Cagliari, Italy., Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G, Tanca FM, Macciò A, Mantovani G

المصدر: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2012 Apr; Vol. 31 (2), pp. 176-82. Date of Electronic Publication: 2011 Nov 01.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8309603 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1983 (Electronic) Linking ISSN: 02615614 NLM ISO Abbreviation: Clin Nutr Subsets: MEDLINE

مواضيع طبية MeSH: Anorexia/*drug therapy , Cachexia/*drug therapy , Carnitine/*therapeutic use , Megestrol Acetate/*therapeutic use , Neoplasms/*complications , Pyrazoles/*therapeutic use , Sulfonamides/*therapeutic use, Absorptiometry, Photon ; Aged ; Aged, 80 and over ; Anorexia/complications ; Appetite ; Cachexia/complications ; Celecoxib ; Combined Modality Therapy ; Drug Combinations ; Endpoint Determination ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/drug therapy ; Patient Compliance ; Quality of Life ; Treatment Outcome

المؤلفون: Macciò A; Department of Obstetrics and Gynecology, Sirai Hospital, Carbonia, Italy. a.maccio@tin.it, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F, Mantovani G

المصدر: Gynecologic oncology [Gynecol Oncol] 2012 Mar; Vol. 124 (3), pp. 417-25. Date of Electronic Publication: 2011 Dec 20.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antioxidants/*therapeutic use , Cachexia/*drug therapy , Carnitine/*therapeutic use , Genital Neoplasms, Female/*drug therapy , Genital Neoplasms, Female/*metabolism , Megestrol Acetate/*therapeutic use , Pyrazoles/*therapeutic use , Sulfonamides/*therapeutic use, Adult ; Aged ; Antioxidants/adverse effects ; Cachexia/metabolism ; Cachexia/pathology ; Carnitine/adverse effects ; Celecoxib ; Female ; Genital Neoplasms, Female/pathology ; Humans ; Inflammation/metabolism ; Inflammation/pathology ; Megestrol Acetate/adverse effects ; Middle Aged ; Prospective Studies ; Pyrazoles/adverse effects ; Quality of Life ; Sulfonamides/adverse effects ; Treatment Outcome